Singham Returns to Keep Grip on Box Office
Ajay Devgn-starrer Singham Returns continued its good performance at the box office, raking in close to Rs 15 crore on Monday, according to trade analyst Taran Adarsh. This takes domestic collections of Singham Returns to Rs 92.47 crore net in four days, adds Mr Adarsh.
Singham Returns has also seen a strong reception at overseas box office. According to Eros, which distributed Singham Returns in the overseas markets, the action thriller grossed nearly Rs 15 crore in its first weekend.
Singham Returns, which was released on Independence Day, had hit the Rs.50 crore-mark in just two days. Directed by Rohit Shetty, Singham Returns also stars Kareena Kapoor and Amole Gupte.
Starring Ajay Devgn as a police inspector, the movie seems to be on its way to becoming a blockbuster just like its prequel Singham that was released in 2011. Singham had done business over Rs 100 crore.
Singham Returns is co-produced by Ajay Devgn Films, Rohit Shetty Productions and Reliance Entertainment. There are expectations that Singham Returns could hit the Rs 100 crore mark in five days. Kick, which is currently the biggest grosser so far in 2014, had also hit the Rs 100 crore milestone in five days. (With Agency Inputs)
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.